Peripheral artery disease (PAD) represents a significant global health burden, affecting millions of individuals worldwide, and its prevalence is significantly higher in individuals with known risk ...

Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put two of the biopharma's programs on hold in response to a case of nerve disease from a former ...